Dexcom Inc. stock gains as insider sales and valuation come into focus
Published on 09/18/2026 at 13:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Dexcom Inc. stock (ISIN US2521311074) ended the September 17, 2026 Nasdaq session at USD 87.93, up 0.68% from the previous close and continuing a solid year-to-date advance in the continuous glucose monitoring specialist.
Stock holds near recent highs
According to Yahoo Finance, Dexcom shares closed at USD 87.93 on Nasdaq on September 17, 2026, with the regular session ending at 4:00 p.m. Eastern Time and a modest after hours indication around USD 88.09 later that day.
Price data from a U.S. trading portal show that on September 17, 2026 Dexcom stock traded between an intraday low of USD 87.17 and a high of USD 88.25, leaving the closing price roughly USD 1.76 above the day low and USD 0.32 below the intraday high, a narrow range that underscores the stock's consolidation just below recent peaks.Robinhood
Insider sales and valuation backdrop
Fresh regulatory filings summarized by a Chinese financial portal show that on September 15, 2026 Dexcom director Nicholas Augustinos sold 6,539 shares at an average price of USD 84.04, for a transaction value of about USD 549,537.56, leaving him with 38,986 shares, corresponding to roughly 0.01% of the company.Sina Finance
A separate filing reported by the same outlet indicates that on the same date, September 15, 2026, Dexcom officer Michael Jon Brown sold 1,700 shares, also at an average price of USD 84.04, for proceeds of about USD 142,868.00, after which his holding stood at 25,049 shares, likewise around 0.01% of the outstanding share count.Sina Finance
These insider disposals took place at levels roughly USD 3.89 below the September 17, 2026 closing price of USD 87.93, reflecting share sales into a rising market but not suggesting a large-scale exit given the low residual ownership percentages.Yahoo Finance
Analyst targets and recent returns
As of mid September 2026, an analyst overview on a U.S. investment site points to a consensus price target of USD 94.48 for Dexcom stock, implying around 7.3% upside from an illustrative reference price of USD 88.09 cited in the same article.StockStory
The same analysis notes that at a share price of USD 88.09 Dexcom trades at around 31 times forward earnings, underscoring that the stock commands a premium valuation for its continuous glucose monitoring franchise.StockStory
A separate data snapshot from a retail brokerage platform indicates that Dexcom's market capitalization stands around USD 33.27 billion at a share price near USD 88.18, placing the company among the larger pure-play medical device makers focused on diabetes technology.Robinhood
Closing price and trading venue
Dexcom Inc. stock is listed on Nasdaq under the ticker DXCM, with the most recent completed regular session closing price of USD 87.93 on September 17, 2026 serving as the current reference level for investors.
Dexcom Inc. stock profile
- Company: Dexcom Inc.
- ISIN: US2521311074
- Ticker: DXCM
- Trading venue: Nasdaq
- Price (as of September 17, 2026, 16:00): 87.93 USD
- Market capitalization: 33.27 billion USD (as of September 17, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
